Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Succinylated gelatin electrolyte sodium acetate injection for ANH in elective surgery
NCT06977750Recruiting
- Sponsor
- Nanjing Chia-Tai Tianqing Pharmaceutical
- Start
- Apr 2025
- Primary completion
- Oct 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of gelofusine + sodium chloride in hypovolemia (2 arms), sponsored by Nanjing Chia-Tai Tianqing Pharmaceutical. Primary endpoint: Change in Stroke Volume. Started Apr 2025; status: recruiting.
02
Drugs
gelofusine + sodium chloride
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT06977750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06977750.